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The effect of oral administration of the leaf extract of Chrysophyllum albidum G. on biochemical and 
haematological parameters were investigated in albino rats for 16 days. The extract did not show any 
significant effect (p > 0.05) on the plasma concentrations of total bilirubin, albumin and alkaline 
phosphatase (ALP) as well as the packed cell volume (PCV), haemoglobin (Hb), red blood cell (RBC), 
reticulocytes, neutrophils, lymphocytes, eosinophils, basophils, mean corpuscular haemoglobin 
concentration (MCHC) and mean corpuscular haemoglobin (MCH). The concentration of the platelets 
was significantly decreased (p < 0.05) at 1000 mg/kg body weight, while white blood cell (WBC) was 
significantly increased at 500 mg/kg body weight. The doses significantly reduced (p < 0.05) plasma 
levels of AST, ALT, total protein, glucose and creatinine while urea was significantly increased. While 
the extract significantly increased the lung, brain and liver-body weights, the kidney, heart, testis, 
spleen and epididymis-body weights were not significantly affected. The result suggests that the leaf 
extract of C. albidum contains antiplatelet and hypoglycemic properties and exhibited selective organ 
toxicity to the rats.  
 





Medicinal plants are plants which contain substances that 
could be used for therapeutic purposes or which are 
precursors for the synthesis of useful drugs (Abolaji et al., 
2007). Medicinal plants, since time immemorial have 
been used in virtually all cultures as a source of medicine. 
Over 5000 plants are known to be used for medicinal pur-
poses in Africa, but only a few have been described or 
studied (Taylor et al., 2001).Natural products from plants 
can be another potent source for the discovery of 
excellent biological activities, that is: anticancer and 
antioxidant activities (Adebayo et al., 2010). Chryso-
phyllum albidum, from the Sapotaceae family, is 
commonly found in the Central, Eastern and Western 
Africa (Amusan et al., 2003). They are distributed in 
Nigeria, Uganda, Niger, Cameroun and Cote d’ Ivoire 
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and distributed throughout  the  southern  part  of  Nigeria 
(Idowu et al., 2006). In South-western Nigeria, the fruit is 
called “agbalumo” and popularly referred to as “udara” in 
South-eastern Nigeria. C. albidum is a popular tropical 
fruit tree and widely distributed in the low land rain forest 
zones and frequently found in villages (Madubuike and 
Ogbonnaya, 2003). The roots, barks and leaves of C. 
albidum have been employed in folk medicine for the 
treatment of diseases. The bark is used for the treatment 
of yellow fever and malaria, while the leaf is used as an 
emollient and for the treatment of skin eruption, 
stomachache and diarrhea (Adisa, 2000; Idowu et al., 
2006). The cotyledons from the seeds of C. albidum are 
used as ointments in the treatment of vaginal and 
dermatological infections in Western Nigeria. The fruit 
pulp is rich in vitamin C and iron and an excellent source 
of raw material for industries (Adisa, 2000; Akubugwo 
and Ugbogu, 2007). Tannins, flavonoids, terpenoids, 
proteins, carbohydates and resins are the 
phytochemicals that have been reported in C. albidum 
(Akaneme, 2008). Bioassay-guided fractionation of the  




methanolic extract of the cotyledons from the seeds of C. 
albidum led to the isolation of eleagnine, tetrahydro- 2 -
methylharman and skatole. Eleagnine was found to be 
the main compound responsible for its antimicrobial 
activity (Idowu et al., 2003). Eleagnine was further shown 
to exhibit anti-nociceptive, anti-inflammatory and anti-
oxidant activities (Idowu et al., 2006). The seed cotyledon 
has been reported to possess anti-hyperglycemic and 
hypolipidemic effects (Olorunnisola et al., 2008). 
Information on the safety potential of this plant is lacking, 
thus there will be need to evaluate the toxicity potential of 
this popularly used medicinal plant. The study therefore is 
aimed at providing information on the effects of the 
ethanolic leaf extract on biochemical and haematological 
parameters in albino Wistar rats. 
 
 




The leaves of C. albidum G. were collected on February, 2009, in 
Abule-Egun of Lagos State, Nigeria and a voucher specimen (PCG 
435) was deposited in the Department of Pharmacognosy, University of 
Lagos, Lagos, Nigeria. The leaves of the plant collected were air-





The method used was as described by Adebayo et al. (2006). The 
powdered leaves of C. albidum (778 g) were soaked in 7 L of 70% 
ethanol for four days, after which the extract was filtered using a 
Whatman no. 1 filter paper and a cotton wool. It was further con-
centrated at 50°C using a rotary evaporator and further con-
centrated using water bath at 48°C. The weight of the extract 





Male albino rats (25) of Wistar strain obtained from Nigerian 
Institute of Medical Research (NIMR), weighing between 100 - 160 
g were used and maintained under laboratory conditions: humidity, 
temperature (23 - 25°C) and light 12 h light/dark cycle in the Animal 
House of the Department of Biological Sciences, Covenant 
University, Ota, Ogun State, Nigeria and were allowed free acces-
ses to grower mash and water ad libitum. The animals were 
acclimatized for four weeks. All animals were treated in a manner 
that complied with the National Institutes of Health (NIH) Guidelines 






Twenty-eight male albino Wistar rats were used for the study. The 
rats were divided into four groups of seven rats per group. The 
crude extract was dissolved in normal saline (0.9% (w/v) NaCl) 
before the treatment. Groups 1, 2, 3 and 4 were used for the sub-
chronic experiment. Groups 2, 3 and 4 were, respectively, admini-
stered with 250, 500 and 1000 mg/kg body weight of ethanolic leaf 
extract of C. albidum for 16 days via gastric intubation. Further-
more, animals in group 1 (control group) did not receive the extract, 





three day interval during the period of administration. After this 
period, the rats were subjected to overnight fast. The rats were 
subsequently anaesthetized  with  diethyl-ether  and  blood  sample 
was collected by cardiac puncture into EDTA and lithium heparin 
bottles. The heparinized samples were centrifuged at 3,000 x g for 
10 min to obtain the plasma and stored at - 20°C until ready for 
analysis; while the whole blood samples were maintained at 4°C, 





Commercial test kits obtained from Roche Diagnostics, GmbH, 
Mannhein, Germany were used for all biochemical parameters 
measured using Uniscope 23D spectrophotometer, England. The 
following biochemical parameters were carried out in plasma: 
alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) were estimated using Reitman and Frankel’s (1957) method; 
alkaline phosphatase (ALP) was carried out using the phenol-
phthalein monophosphate method (Babson et al., 1966); total 
bilirubin was calculated using Doumas et al. (1973) method; total 
protein was determined using biuret method (Peters, 1968); glu-
cose level was obtained using the enzymatic GOD-PAP method 
(Trinder, 1969); urea was analysed using the Bethlot Searcy’s 
method (Searcy, 1967); creatinine was determined by the method 
described by Larsen (1971), and albumin was estimated by bromo 





The haematological parameters (red blood cell count (RBC), hae-
moglobin (Hb), packed cell volume (PCV), white blood cell count 
(WBC), mean cell volume (MCV), mean corpuscular haemoglobin 
(MCH), mean corpuscular haemoglobin concentration (MCHC), 
platelet (PLT) count, reticulocytes and WBC differentials (neutrophils, 
monocytes, lymphocytes, basophils and eosinophil) were analyzed 
according to the standard techniques described by Baker et al. 





The differences among experimental and control groups were 
determined using SPSS for Window XP Software Programme 
(version 13.0). Group comparisons were done using the analysis of 
variance (ANOVA) test. Significant differences between control and 
experimental were assessed by least significant difference (LSD) 
and student’s t-test. All data were expressed as mean ± SEM; p-





No deaths occurred in the period of treatment. No change 
in locomotor activity was observed. There was no 
significant change in body weights of the treated groups 
when compared to the control group (Figure 1). There 
was also no significant difference (p > 0.05) in the relative 
and absolute weights of kidney, testis, heart, spleen and 
epididymis during the treatment period. The relative 
weights (weights of organ with respect to the body 
weight) of the liver and lungs were significantly increased 
(p < 0.05) in the group treated with 1000 mg/kg body 
weight of the extract of C. albidum. The weight of brain 
was also significantly elevated (p < 0.05) in the groups  










treated   with  500  and  1000 mg/kg  body  weight  of  the 
extract (Table 1). The ethanolic extract of C. albidum did 
not have any significant effect on RBC, Hb, MCHC, MCH, 
reticulocytes, neutrophils, basophils, monocytes, lympho-
cytes and eosinophils. While WBC was significantly 
elevated (p < 0.05) in the group treated with 500 mg/kg 
body weight, the platelet was significantly reduced (p < 
0.05) in rats treated with 1000 mg/kg body weight (Table 
2). Plasma glucose level was significantly reduced (p < 
0.05) in the group administered with 500 mg/kg body 
weight. The extract did not exact any significant effect (p 
> 0.05) on alkaline phosphatase (ALP), total bilirubin and 
albumin. Aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and creatinine were significantly 
decreased (p < 0.05) in all the treated groups. There was 
a significant reduction (p < 0.05) in total protein in the 
group treated with 1000 mg/kg body weight of the extract. 
Similarly, there was a significant increase (p < 0.05) in 
urea in all the groups treated as compared to the control 





The various biochemical and haematological parameters 
investigated in this study are useful indices of evaluating 
the toxicity of plant extract in animals (Yakubu et al., 
2008). Assessment of haematological parameters can 
not only be used to determine the extent of deleterious 
effect of extracts on the blood of an animal, but it can 
also be used to explain blood relating functions of a plant 
extract or its products (Yakubu et al., 2007). Analysis of 
blood parameters is relevant in risk evaluation as 
changes in the haematological system have higher 
predictive value for human toxicity when the data are 
translated from animal studies (Olson et al., 2000). From 
the observed significant values of WBC, it is clear that an 
increase in the number of WBC is a normal reaction of 
rats to foreign substances, which alter their normal 
physiological processes. The leucocytosis observed in 
the present study indicates a stimulation of the immune 
system which protects the rats against infection that 
might have been caused by chemical and secondary 
infections. Leucocytosis, which may be directly propor-
tional to the severity of the causative stress condition, 
may be attributed to an increase in leukocyte mobilization 
(Celik and Suzek, 2008). 
The non-significant effect of the extract on the RBC 
may be an indication that the balance between the rate of 
production (erythropoiesis) and destruction of the blood 
corpuscles was not altered. MCHC and MCH relate to 
individual red blood cells while Hb, RBC and PCV are 
associated with the total population of red blood cells. 
Therefore, the absence of significant effect of the extract 
on RBC, Hb, PCV, MCH and MCHC could mean that 
neither the incorporation of haemoglobin into red blood 
cells nor the morphology and osmotic fragility of the red 
blood cells was altered (Adebayo et al., 2005). C. 
albidum extract exerts a significant reduction in the plate-
lets which indicates thrombocytopenia. Platelet aggregation 
plays a pivotal role in the physiopathology of thrombotic 
diseases. Moreover, platelet activity may play a major 
role in the development as well as in the stability of 
atherosclerotic plaques and as a consequence, anti-
platelet agents have  been  used  clinically  in  patients  at  




Table 1. Effect of ethanolic leaf extract of Chrysophyllum albidum on the weight of organs. 
 
Organs Group 1 (Control) 
Group 2 
(250 mg/kg bw) 
Group 3 
(500 mg/kg bw) 
Group 4 
(1000 mg/kg bw) 
Kidney 0.94 ± 0.09a 0.93 ± 0.07 a 0.97 ± 0.06 a 0.84 ± 0.05 a 
[0.68 ± 0.03]a [0.71± 0.03] a [0.77± 0.05] a [0.70 ± 0.03] a 
Spleen 0.74 ± 0.10a 0.69 ± 0.07 a 0.62 ± 0.09 a 0.66 ± 0.12 a 
[0.53 ± 0.06]a [0.52 ± 0.04] a [0.49 ± 0.07] a [0.54 ± 0.08] a 
Liver 7.76 ± 0.88a 7.80 ± 0.27 a 7.67 ± 0.61 a 7.60 ± 0.40 a 
[5.50 ± 0.20]a [6.01 ± 0.20] a [6.01± 0.22] a [6.33 ± 0.21] b 
Heart 0.56 ± 0.04a 0.54 ± 0.02 a 0.50 ± 0.04 a 0.47 ± 0.02 a 
[0.41± 0.03]a [0.42± 0.01] a [0.39 ± 0.01] a [0.40± 0.02] a 
Epididymis 0.38 ± 0.09 a 0.52 ± 0.05 a 0.28 ± 0.06 a 0.47 ± 0.09 a 
[0.26± 0.09] a [0.39 ± 0.10] a [0.22 ± 0.10] a [0.38 ± 0.15] a 
Testis 1.68 ± 0.29 a 1.72 ± 0.16 a 1.75 ± 0.21 a 1.50 ± 0.11 a 
[1.17 ± 0.03] a [0.24± 0.03] a [1.41± 0.03] a [1.27± 0.03] a 
Brain 1.26 ± 0.12 a 1.43 ± 0.09 a 1.53 ± 0.05 a 1.64 ± 0.04 a 
[0.96 ± 0.17] a [1.10 ± 0.07] a [1.22 ± 0.07] b [1.38 ± 0.07] b 
Lung 1.04 ± 0.16 a 0.96 ± 0.09 a 1.00 ± 0.09 a 1.14 ± 0.07 a 
[0.75 ± 0.10] a [0.75 ± 0.09] a [0.79 ± 0.04] a [0.95 ± 0.04] b 
 
Values represent mean ± SEM of 7 replicates; values in parenthesis are % weight of organ with respect to 
the body weight of rats.  





risk for myocardial ischemia, unstable angina and acute 
myocardial infarction (Albers, 1995; George, 2000). 
Flavonoid has been shown to act at the blood platelet 
level by preventing platelet activity-related thrombosis 
(Harnafi and Amrani, 2007). C. albidum has been reported 
to contain flavonoids as one of its active compounds 
(Akaneme, 2008). Some studies suggested various 
mechanisms by which flavonoid exert its antiplatelet 
property that is, by lowering intracellular Ca2+ levels; 
alteration in the metabolism of cAMP, and thromboxane 
A2 (Roy et al., 1999; Kang et al., 2001). Thus, it may be 
inferred that the antiplatelet property of the extract of C. 
albidum might be mediated by lowering the intracellular 
Ca2+ levels or by inhibiting key aspects of cAMP and 
thromboxane metabolism. The extract therefore might be 
useful in the management of cardiovascular diseases. 
Tissue damage is usually associated with the release of 
enzymes specific to the affected tissue or organ in 
circulation. The consequence is an increase in the activity 
of such enzymes in body fluids (Aliyu et al., 2006). The 
significant reductions observed in the activity of ALT and 
AST indicate that the extract of C. albidum was not 
harmful to the liver. ALT is a cytoplasmic enzyme found 
in very high concentration in the liver and an increase of 
this specific enzyme indicates hepatocellular damage, 
while AST is less specific than ALT as an indicator of liver 
function (Aliyu et al., 2006). Enhancement in tissue 
serum total protein is an indication of tissue damage 
while a significant decrease in total protein of the liver 
contents is a reflection of hepatic toxicity (Gatsing et al., 
2005). The significant reductions of protein in group 
administered with 1500 mg/kg body weight indicate 
depletion in the protein reserve and thus suggest hepatic 
toxicity. Serum glucose level was significantly lowered in 
the groups treated with 500 and 1000 mg/kg body weight 
suggesting that the leaf extract possess hypoglycemic 
activity. The result corroborates with the study conducted 
on the seed cotyledon of C. albidum which significantly 
decreased blood glucose level in diabetic rats (Olorunnisola 
et al., 2008). The serum creatinine level was decreased 
significantly suggesting that the leaf extract was not toxic 
to the kidney. Creatinine is the major catabolic products 
of the muscle and it is excreted in the kidneys. Creatinine 
levels are used as indicator of renal failure (Aliyu et al., 
2006). The increased level of urea observed is an indica-
tion of azotaemia. High blood urea is associated with   
increased   tissue   protein   catabolism,    excess break-
down of blood protein and diminished excretion of urea 
(Nduka, 1999). An increase in organ-body weight ratio is 
an indication of inflammation while a decrease may be 
due to cell constriction (Moore and Dalley, 1999). The 
increase in the brain, lung and liver-body weight ratio 
observed with the extract may be due to increase in the 
functional ability of the organ (Ashafa et al., 2009). The 
absence of significant effect on the kidney, spleen, testis, 
epididymis and heart-body weight ratios of the animals is 
an indication that the extract did not adversely affect the 
size of these organs in relation to the weight of the 
animals.  
In   conclusion, the  study  has  demonstrated  that  the  




Table 2. Effect of ethanolic leaf extract of Chrysophyllum albidum on haematological parameters in albino 
Wistar rats. 
 
Parameters Group 1 (control group) 
Group 2 
(250 mg/kg bw) 
Group 3 
(500 mg/kg bw) 
Group 4 
(1000 mg/kg bw) 
PCV (%) 38.80 ± 2.78a 38.43 ± 1.11a 38.00 ± 1.84a 35.14 ± 1.28 a 
HB (g/dl) 12.85 ± 0.92a 12.70 ± 0.37a 12.21 ± 0.44a 11.78 ± 0.38a 
RBC (×1012/L) 4.16 ± 0.30 a 4.07 ± 0.13a 4.02 ± 0.16a 3.83 ± 0.14a 
Platelet (×109/L) 247.60 ± 27.01a 212.43 ± 12.43a 224.00 ± 27.95a 184.38 ± 4.33b 
WBC (x1014/L) 63.76 ± 3.55a 87.07 ± 96.07a 134.11 ± 7.49b 84.93 ± 9.97 a 
Reticulocyte (%) 3.40 ± 0.44a 2.86 ± 0.46a 2.77 ± 0.30a 3.23 ± 0.38 a 
Neutrophil (%) 25.80 ± 5.17a 26.00 ± 4.70a 29.17 ± 4.38a 26.29 ± 4.37a 
Lymphocyte (%) 73.40 ± 5.57a 73.57 ± 4.78a 70.83 ± 4.38a 73.57 ± 4.37a 
Monocyte (%) 0.40 ± 0.19a 0.43 ± 0.17a 0.42 ± 0.18a 0.41 ± 0.14a 
Eosinophil (%) 0.40 ± 0.09a 0.41 ± 0.12 a 0.41 ± 0.13a 0.42 ± 0.12a 
Basophil (%) 9.33 ± 0.12a 9.76 ± 0.38 a 9.33 ± 0.56 a 9.18 ± 0.10a 
MCH (pg) 3.09 ± 0.04a 3.12 ± 0.03a 3.02 ± 0.06 a 3.09 ± 0.06a 
MCHC (g/L) 0.33 ± 0.01a 0.33 ± 0.01a 0.32 ± 0.02a 0.34 ± 0.02a 
 
Values represent mean ± SEM of 7 replicates.  
Values on the same row followed by different superscript letters differ significantly (a p > 0.005, b p < 0.05, versus 
control).  
WBC = White blood cell count, RBC = red blood cell count, PVC = packed cell volume, Hb = haemoglobin, MCH = 




Table 3. Effect of ethanolic leaf extract of Chrysophyllum albidum on biochemical parameters of albino Wistar rats 
after 16 days of treatment. 
 
Parameters Group 1 (Control) 
Group 2 
(250 mg/kg bw) 
Group 3 
(500 mg/kg bw) 
Group 4 
(1000 mg/kg bw) 
AST (U/L) 124.6 2 ± 16.73a 79.57 ± 6.80 b 62.5 ± 5.65b 66.71 ± 9.79b 
ALT (U/L) 119.13 ± 15.34a 73.44 ± 7.31b 68.23 ± 4.11b 66.17 ± 5.71b 
Total bilirubin    (mg/dl) 0.22  ± 0.08a 0.16 ± 0.01a 0.18 ± 0.08a 0.19 ± 0.07 a 
ALP (U/L) 314.61 ± 3.10a 316.20 ± 2.48a 303.70 ± 6.34a 314.43 ± 1.68a 
Total protein   (mg/dl) 6.62 ± 0.21a 6.34 ± 0.37a 6.37 ± 0.12a 5.17 ± 0.19 b 
Albumin  (mg/dl) 3.90 ± 0.19 a 4.45 ± 0.29 a 4.11 ± 0.32a 5.16  ± 0.40 a 
Glucose (mg/dl) 187.04 ± 19.41a 177.11 ± 24.53a 119.20 ± 5.54 b 126.80 ± 10.24b 
Urea (mg/dl)       43.43 ± 1.24a 48.50 ± 1.44 b 57.70 ± 0.84b 50.85 ± 1.56 b 
Creatinine (mg/dl) 0.83 ± 0.04a 0.98 ± 0.04b 0.65 ± 0.03b 0.62 ± 0.02b 
 
Values represent mean ± SEM of 7 replicates.  
Values on the same row followed by different superscript letters differ significantly (a p > 0.005, b p < 0.05, versus control). 




leaf extract of C. albidum may not  cause any adverse 
effect on the biochemical and haematological indices of 
toxicity. Moreover, the extract was found to possess anti-
platelet and hypoglycemic properties and might be 
employed in the management of myocardial infarction 
and diabetes mellitus, respectively. Further investigation 
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